2015 Strategies in the UK Tumor Marker Testing Market

2015 Strategies in the UK Tumor Marker Testing Market

Category : Diagnostic and Biotech
Published On : May  2015
Pages : 575

------------ Or -------------

Complete report $5,400.  DataPack (test volumes, sales forecasts, supplier shares) $1,950.


  • Comprehensive 575-page analysis of the UK tumor marker testing market.
  • Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
  • Five-year test volume and sales forecasts over for 40 tumor marker performed in UK hospitals, commercial laboratories and physician offices.
  • Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
  • Current instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains 575 pages and 85 tables

Enquiry Before Buy